Table 4.
Univariable |
Multivariable |
|||||||
---|---|---|---|---|---|---|---|---|
Predictors | >10 fractions | ≤10 fractions | OR | 95% CI | P-value | OR | 95% CI | P-value |
Demographic | ||||||||
Age at time of diagnosis (years) | ||||||||
65-69 | 50% | 50% | ref | < .01 | .02 | |||
70-74 | 49% | 51% | 0.97 | 0.90-1.04 | 1.02 | 0.95-1.10 | ||
75-79 | 47% | 53% | 0.89 | 0.83-0.96 | 0.98 | 0.91-1.06 | ||
>80 | 47% | 53% | 0.89 | 0.82-0.96 | 1.13 | 1.04-1.23 | ||
Sex | ||||||||
Female | 48% | 52% | ref | .70 | .63 | |||
Male | 49% | 51% | 1.01 | 0.96-1.07 | 0.99 | 0.93-1.05 | ||
Race | ||||||||
White | 49% | 51% | ref | .04 | .16 | |||
Black | 46% | 54% | 0.88 | 0.80-0.97 | 0.92 | 0.81-1.04 | ||
Asian/Pacific Islander | 48% | 52% | 0.93 | 0.82-1.06 | 0.97 | 0.66-1.44 | ||
Other | 48% | 52% | 1.25 | 0.81-1.93 | 1.51 | 1.00-2.30 | ||
Marital status | ||||||||
Not married | 47% | 53% | ref | < .01 | .46 | |||
Married | 49% | 51% | 1.10 | 1.04-1.16 | 1.02 | 0.97-1.08 | ||
Diagnosis year | ||||||||
2004-2005 | 48% | 52% | ref | .65 | .68 | |||
2006-2007 | 48% | 52% | 1.00 | 0.93-1.08 | 1.03 | 0.97-1.10 | ||
2008-2009 | 48% | 52% | 1.02 | 0.94-1.10 | 1.02 | 0.94-1.10 | ||
2010-2011 | 49% | 51% | 1.05 | 0.97-1.13 | 1.05 | 0.96-1.14 | ||
Median income quartile (percentile)* | ||||||||
≤25th | 49% | 51% | ref | .11 | .23 | |||
25th-50th | 49% | 51% | 1.02 | 0.94-1.10 | 1.07 | 0.94-1.21 | ||
50th-75th | 47% | 53% | 0.93 | 0.87-1.01 | 0.96 | 0.85-1.09 | ||
>75th | 48% | 52% | 0.96 | 0.89-1.03 | 1.03 | 0.91-1.17 | ||
Clinical and treatment | ||||||||
Modified Charlson comorbidity score† | ||||||||
0 | 49% | 51% | ref | .30 | .57 | |||
1 | 49% | 51% | 1.00 | 0.94-1.07 | 1.00 | 0.93-1.08 | ||
2 | 47% | 53% | 0.94 | 0.86-1.04 | 0.95 | 0.85-1.07 | ||
3 + | 47% | 53% | 0.93 | 0.84-1.02 | 0.95 | 0.87-1.04 | ||
Chemotherapy‡ | ||||||||
No | 39% | 61% | ref | < .01 | < .01 | |||
Yes | 54% | 46% | 1.79 | 1.69-1.89 | 1.74 | 1.61-1.88 | ||
Hospice services‡ | ||||||||
No | 52% | 48% | ref | < .01 | < .01 | |||
Yes | 44% | 56% | 0.73 | 0.69-0.77 | 0.77 | 0.73-0.82 | ||
Regional and health care services | ||||||||
SEER region | ||||||||
Northeast | 43% | 57% | ref | .09 | .07 | |||
South | 50% | 50% | 1.34 | 1.24-1.45 | 1.19 | 1.02-1.39 | ||
Midwest | 49% | 51% | 1.27 | 1.15-1.39 | 1.23 | 1.04-1.46 | ||
West | 49% | 51% | 1.29 | 1.19-1.39 | 1.13 | 0.97-1.33 | ||
Living in urban area | ||||||||
No | 50% | 50% | ref | .09 | .40 | |||
Yes | 48% | 52% | 0.93 | 0.86-1.01 | 1.06 | 0.93-1.20 | ||
Radiation oncologist density§ | ||||||||
Lowest tertile | 50% | 50% | ref | < .01 | .63 | |||
Middle tertile | 47% | 53% | 0.90 | 0.84-0.96 | 0.96 | 0.85-1.09 | ||
Highest tertile | 48% | 52% | 0.92 | 0.86-0.99 | 1.01 | 0.90-1.13 | ||
RT facility type | ||||||||
Hospital-based | 44% | 56% | ref | < .01 | < .01 | |||
Freestanding | 58% | 43% | 1.74 | 1.65-1.84 | 1.74 | 1.60-1.89 |
CI, confidence interval; OR, odds ratio; ref, reference group; RT, radiation therapy; SEER, Surveillance, Epidemiology and End Results.
By ZIP code.
Measured using the Klabunde modification.
Within 1 year of diagnosis.
Number of radiation oncologists (per 100,000 population) practicing within each patient's county of residence, divided into top (>1.5), middle (1-1.5), and bottom (<1) tertiles.